Seeyond Alnylam Pharmaceuticals, Inc. Transaction History

Seeyond

$1.03 Billion
Q4 2022

A detailed history of Seeyond transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Seeyond holds 438 shares of ALNY stock, worth $106,574. This represents 0.01% of its overall portfolio holdings.

Number of Shares

438

Previous 6,627 93.39%

Holding current value

$106,574

Previous $1.33 Million 92.16%

% of portfolio

0.01%

Previous 0.16%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$185.53 - $241.31 $1.15 Million - $1.49 Million	-6,189 Reduced 93.39%	438 $104,000
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $428,227 - $717,112	3,091 Added 87.42%	6,627 $1.33 Million
Q2 2022 Aug 12, 2022	SELL	$120.42 - $169.29 $8,549 - $12,019	-71 Reduced 1.97%	3,536 $515,000
Q1 2022 May 13, 2022	SELL	$127.18 - $173.91 $487,989 - $667,292	-3,837 Reduced 51.54%	3,607 $588,000
Q3 2021 Nov 12, 2021	SELL	$169.75 - $207.73 $392,292 - $480,064	-2,311 Reduced 23.69%	7,444 $1.41 Million

Q2 2021 Aug 13, 2021	BUY	$128.63 - $176.89 $5,659 - $7,783	44 Added 0.45%	9,755 $1.65 Million
Q1 2021 May 14, 2021	SELL	$126.83 - $175.69 $1.33 Million - $1.84 Million	-10,457 Reduced 51.85%	9,711 $1.37 Million
Q4 2020 Feb 12, 2021	BUY	$122.97 - $147.0 $360,916 - $431,445	2,935 Added 17.03%	20,168 $2.62 Million
Q3 2020 Nov 12, 2020	BUY	$121.19 - $165.49 $218,384 - $298,212	1,802 Added 11.68%	17,233 $2.51 Million
Q2 2020 Aug 13, 2020	BUY	$104.21 - $156.44 $942,892 - $1.42 Million	9,048 Added 141.75%	15,431 $2.29 Million
Q1 2020 May 14, 2020	BUY	$93.12 - $133.99 $468,766 - $674,505	5,034 Added 373.17%	6,383 $364,000
Q2 2019 Aug 13, 2019	SELL	$65.86 - $92.79 $19,494 - $27,465	-296 Reduced 17.99%	1,349 $98,000
Q4 2018 Feb 14, 2019	BUY	$62.67 - $88.33 $103,092 - $145,302	1,645 New	1,645 $120,000

Others Institutions Holding ALNY

# of Institutions

585

Shares Held

104M

Call Options Held

2.82M

Put Options Held

1.75M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29.9B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Seeyond, based on Form 13F filings with the SEC.

News

Stay updated on Seeyond with notifications on news.

Account